Richard F. Little, M.D.

Richard F. Little, M.D.
Adjunct Investigator
Head, Hematologic, HIV and Stem Cell Therapeutics
Clinical Investigations Branch, CTEP, NCI

Dr. Little joined the NCI's Cancer Therapy and Evaluation Program (CTEP) as head of the therapeutics section for Hematologic and AIDS-related Cancers and Hematopoietic Stem Cell in April 2007.  His focus is to oversee, review, and coordinate the NCI-sponsored phase III cancer treatment trials in these diseases in an effort to promote practice-changing and definitive clinical trials.

Dr. Little's research interests have focused on immune suppression-related neoplastic disease, investigation of viral targets for oncolytic therapy and immunotherapy, and antiangiogenesis.

For more information about Dr. Little, visit his CTEP website.

Areas of Expertise

1) hematologic cancers, 2) AIDS-related cancers

Contact Info

Richard F. Little, M.D.
Center for Cancer Research
National Cancer Institute
9609 Medical Center Dr., Room 5W426
Rockville, MD 20892-9739
Ph: 240-276-6560
Fax: 240-276-7892